In both cases, ACP6 mRNA expression was significantly downregulated in cancer patients carrying mutations in the TP53 gene, suggesting that mutant p53 can suppress ACP6 transcription in human tumors (Fig. 4h,i). The gene discussed is ACP6; the disease is cancer.